Stroke Prevention Across Diverse NVAF Patient Types - What the GP needs to know - QI&CPD - Category 2
Atrial fibrillation is the most common recurrent arrythmia managed in clinical practice. GPs may encounter clinical challenges when managing patients with NVAF due to comorbidities including increased risk of stroke. This 1-hour accredited program summarises the issues around bleeding management, high ICH risk, emergency reversal and post-PCI management in NVAF patients. Featuring four diverse case studies, presented to a cardiologist, neurologist and haematologist by GP Dr Brad McKay, the program focuses on the most important questions around NOAC use for the general practitioner.
This activity has been approved by The Royal Australian College of General Practitioners QI&CPD Program.
Total Points: 2 Point(s) (Category 2)
Dr Brad McKay
Professor Christopher Ward
BMedSc, MBChB w Dist. PhD (Monash), FRACP, FRCPA
Dr Timothy Ang
MBBS, FRACP, CCINR
Professor Andrew Sindone
B.Med(Hons), MD, FRACP, FCSANZ, FNHFA
On completion of this program, participants will be better able to:
- Systematically identify patients with non-valvular atrial fibrillation (NVAF), through appropriate screening and ECG interpretation, and immediately initiate oral anticoagulation therapy where appropriate
- Communicate the benefits versus risks of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin to patients with NVAF based on evidence from randomised controlled trials (RCTs) and real-world evidence
- Address some of the clinical challenges encountered when managing patients with NVAF, including screening for and managing comorbidities, and minimising the risk of bleeding
- Review and apply management strategies for NVAF patients who require emergency surgery or experience a life-threatening bleed